CytoMed Therapeutics Ltd (GDTC) shareholders
Close on Nov 17, 2026Market cap $9.26MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Choo Chee Kong | 3,003,996 | 25.17% | 13D (active) amendment | Oct 12, 2026 |
| mDR LTD | 1,191,523 | 9.98% | 13G (passive) amendment | Oct 12, 2026 |
| Wang Shu | 883,858 | 7.66% | 13G (passive) | Feb 14, 2024 |
| 28 Consultants Ltd | 880,313 | 7.62% | 13G (passive) | Feb 17, 2025 |
| Zeng Jieming | 589,239 | 5.11% | 13G (passive) | Feb 14, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GDTC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Axiom Investment Management LLC | 7,032 | 0.06% | $7.24K | New | 0.00% |
| UBS Group AG | 4,831 | 0.04% | $4.98K | −1,351 | 0.00% |
| Osaic Holdings, Inc. | 21 | 0.00% | $21 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 3 | 0M | 0.1% | 1 / 0 | 1 / 1 | 0M | 0M |
| Q1 2026 | 3 | 0M | 0.1% | 1 / 1 | 0 / 3 | 0M | 0M |
| Q4 2025 | 5 | 0M | 0.4% | 4 / 0 | 1 / 1 | 0M | 0M |
| Q3 2025 | 2 | 0M | 0.2% | 1 / 0 | 1 / 1 | 0M | 0M |
| Q2 2025 | 2 | 0M | 0.4% | 0 / 2 | 0 / 0 | 0M | 0M |
| Q1 2025 | 2 | 0M | 0.3% | 1 / 1 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.1% | 0 / 1 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 0 / 0 | 1 / 1 | 0M | 0M |
| Q4 2023 | 2 | 0M | 0.0% | 1 / 1 | 0 / 1 | 0M | 0M |
| Q3 2023 | 2 | 0M | 0.0% | 1 / 1 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yvonne Goh | Chief Financial Officer | 25,781 | 0.22% | May 15, 2026 |
| Yoong Ying Tan | Chief Corporate Officer | 25,781 | 0.22% | May 15, 2026 |
| Chee Kong Choo | Director, 10% owner | 2,899,746 | 24.52% | Jul 24, 2026 |
| Keng Kiat Toh | Director | 4,000 | 0.03% | May 26, 2026 |
| Mark Kei Wei Leong | Director | – | – | May 15, 2026 |
| Chak Hua Yew | Director | 2,469 | 0.02% | May 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Chee Kong Choo Director, 10% owner | Jul 20, 2026 | Buy | +100,000 | $1.50 | $150.00K | 630,324 |
| Chee Kong Choo Director, 10% owner | Jul 20, 2026 | Buy | −100,000 | $1.50 | $150.00K | 630,324 |
| Chee Kong Choo Director, 10% owner | Jul 14, 2026 | Buy | +100,000 | $1.50 | $150.00K | 530,324 |
| Chee Kong Choo Director, 10% owner | Jul 14, 2026 | Buy | −100,000 | $1.50 | $150.00K | 530,324 |
| Chee Kong Choo Director, 10% owner | May 13, 2026 | Buy | +112,000 | $1.15 | $128.80K | 430,324 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CytoMed Therapeutics's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| mDR Ltd 10% Stockholder | Aug 11, 2026 | 117,337 | $103.26K | Aug 11, 2026 | Share Subscription |
| mDR LTD 10% Stockholder | May 13, 2026 | 117,337 | $98.09K | May 13, 2026 | Share Subscription |
| mDR LTD 10% Stockholder | Feb 12, 2026 | 117,337 | $122.03K | Feb 12, 2026 | Share Subscription |
| mDR Ltd 10% Stockholder | Sep 22, 2025 | 54,644 | $102.73K | Sep 23, 2025 | Share Subscription |
| mDR Ltd 10% Stockholder | Jun 23, 2025 | 81,482 | $171.11K | Jun 23, 2025 | Share Subscription |
| mDR Ltd 10% Stockholder | Mar 24, 2025 | 86,410 | $229.85K | Mar 24, 2025 | Share Subscription |
| mDR Ltd 10% Stockholder | Nov 4, 2024 | 115,400 | $266.00K | Nov 5, 2024 | Share Subscription |
See a number that looks wrong?